Skip to content

LISATA THERAPEUTICS, INC.: 10-Q filed 2012-11-13

What LISATA THERAPEUTICS, INC. reported in its quarterly report filed 2012-11-13 (fiscal Q3 2012): 42 published measures, 115 facts as tagged in accession 0000320017-12-000019.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-13
Fiscal period
fiscal Q3 2012
Accession
0000320017-12-000019 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LISATA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-30128,806,060USD
At 2011-12-31155,327,780USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-3048,209,993USD
At 2011-12-3162,025,557USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-305,390,611USD
At 2011-12-313,935,160USD
At 2011-09-3010,164,987USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-8,410,909USD92
2012-01-01 to 2012-09-30-38,264,381USD274
2011-07-01 to 2011-09-30-7,346,435USD92
2011-01-01 to 2011-09-30-28,287,815USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-4,227,631USD274
2011-01-01 to 2011-09-30-17,522,431USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-09-30197,577USD274
2011-01-01 to 2011-09-30506,783USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-07-01 to 2012-09-304,433,961USD92
2012-01-01 to 2012-09-3011,578,783USD274
2011-07-01 to 2011-09-302,177,013USD92
2011-01-01 to 2011-09-305,836,978USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-3010,422,534USD274
2011-01-01 to 2011-09-3016,516,524USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-2,688,108USD274
2011-01-01 to 2011-09-30-3,127,902USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-30-181,622,667USD
At 2011-12-31-143,094,854USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-3011,067,570USD
At 2011-12-3111,616,053USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-8,089,003USD92
2012-01-01 to 2012-09-30-22,442,897USD274
2011-07-01 to 2011-09-30-7,230,450USD92
2011-01-01 to 2011-09-30-26,449,362USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-3047,886,255USD
At 2011-12-3138,610,336USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-30384,168USD92
2012-01-01 to 2012-09-301,359,187USD274
2011-07-01 to 2011-09-30632,837USD92
2011-01-01 to 2011-09-302,060,068USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-3050,435,274USD
At 2011-12-3136,446,644USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-302,570,879USD
At 2011-12-312,287,201USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2012-09-3011,117,770USD
At 2011-12-3111,117,770USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-09-3014,632,100USD
At 2011-12-3115,086,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-09-301,794,579USD
At 2011-12-311,010,475USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-308,775,474USD92
2012-01-01 to 2012-09-3024,582,495USD274
2011-07-01 to 2011-09-307,516,129USD92
2011-01-01 to 2011-09-3026,950,261USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-09-30448,045USD
At 2011-12-31647,745USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-30686,471USD92
2012-01-01 to 2012-09-302,139,598USD274
2011-07-01 to 2011-09-30285,679USD92
2011-01-01 to 2011-09-30500,899USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2012-07-01 to 2012-09-303,747,490USD92
2012-01-01 to 2012-09-309,439,185USD274
2011-07-01 to 2011-09-301,891,334USD92
2011-01-01 to 2011-09-305,336,079USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-07-01 to 2012-09-305,947,264USD92
2012-01-01 to 2012-09-3017,092,493USD274
2011-07-01 to 2011-09-305,975,688USD92
2011-01-01 to 2011-09-3021,293,386USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-302,828,210USD92
2012-01-01 to 2012-09-307,490,002USD274
2011-07-01 to 2011-09-301,540,441USD92
2011-01-01 to 2011-09-305,656,875USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-30155,141,086shares
At 2011-12-31109,329,587shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-09-30225,528,652USD
At 2011-12-31200,858,638USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-09-304,148,767USD
At 2011-12-314,152,343USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-09-3053,706,468USD
At 2011-12-3180,132,518USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-09-3014,632,130USD
At 2011-12-3115,086,038USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-09-30932,474USD
At 2011-12-313,326,938USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-09-30139,276USD
At 2011-12-310USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-09-301,385,510USD
At 2011-12-311,090,176USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-09-303,228,775USD
At 2011-12-31649,739USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-8,395,957USD92
2012-01-01 to 2012-09-30-51,025,744USD274
2011-07-01 to 2011-09-30-7,328,464USD92
2011-01-01 to 2011-09-30-27,728,736USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-8,436,474USD92
2012-01-01 to 2012-09-30-38,267,957USD274
2011-07-01 to 2011-09-30-4,488,971USD92
2011-01-01 to 2011-09-30-27,115,302USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-9,490,925USD92
2012-01-01 to 2012-09-30-39,540,632USD274
2011-07-01 to 2011-09-30-7,497,090USD92
2011-01-01 to 2011-09-30-28,795,885USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-07-01 to 2012-09-30151,300USD92
2012-01-01 to 2012-09-30453,900USD274
2011-07-01 to 2011-09-30211,300USD92
2011-01-01 to 2011-09-30591,200USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-74,881USD92
2012-01-01 to 2012-09-3036,924USD274
2011-07-01 to 2011-09-301,292,911USD92
2011-01-01 to 2011-09-301,572,807USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-459,049USD92
2012-01-01 to 2012-09-30-1,322,263USD274
2011-07-01 to 2011-09-30660,074USD92
2011-01-01 to 2011-09-30-487,261USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-301,112,107USD274
2011-01-01 to 2011-09-30944,206USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-199,700USD274
2011-01-01 to 2011-09-30-779,043USD273

Inspect the source

Entity
LISATA THERAPEUTICS, INC. / CIK 0000320017
Captured
2026-09-19T14:56:51.274Z
SEC response SHA-256
cea21c045f03a86f28b8ca2c2ed8647182755ec7b9afe40200702f5307c095db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000320017.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))